ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Live MANKIND 2200 PE (PUT) 27 January 2026 options price chart analysis Mankind Pharma Limited

Live Options premium chart analysis for Live MANKIND 2200 PE (PUT) 27 January 2026 options price chart analysis Mankind Pharma Limited

Mankind Pharma Limited MANKIND trades in NSE under NSE

MANKIND 2200 PE Live prices

What is premium price of MANKIND 2200 PE PUT today?
Premium of MANKIND 2200 PE is 62.90 on 04 Dec 2025 PUT opened at 62.90 and traded inside a Low-High range of 62.90-62.90 today. Please click here table for more current prices.
What is open interest of MANKIND 2200 PUT PE today?
Open Interest of MANKIND 2200 PE is 2700 today. This has changed 0.00 from previous day.
What is underlying price of MANKIND 2200 PE PUT today?
Underlying price of MANKIND 2200 PE PUT is 2206.30 today.
What is lot size of MANKIND 2200 PUT PE today?
Lot size of MANKIND 2200 PUT PE is 225.00
Is MANKIND 2200 PE PUT ITM or OTM or ATM?
MANKIND 2200 PUT PE is OTM PUT option (out of the money). Only ITM options have intrinsic value in them, while OTM options have only time value in them.

Underlying equity prev closing: 2206.30

MANKIND PUT PE available options strikes

PE 2100, PE 2150, PE 2200, PE 2250, PE 2300, All CE , All PE

MANKIND 2200 PUT PE available expiry dates

30 Dec 202527 Jan 202624 Feb 2026

Premium of MANKIND 2200 PUT PE January 27 2026

MANKIND 2200 PE Live prices

Premium of PUT (PE) of strike 2200 is at: 62.90 on 04 Dec 2025
PUT opened at 62.90 and traded inside a Low-High range of 62.90-62.90 as on 04 Thu Dec 2025

The underlying equity is trading at 2206.30 which means that PUT of strike 2200 is OTM PUT option (out of the money)

Lot size of MANKIND Mankind Pharma Limited is 225

Total Open Interest for PUT (PE) of strike 2200 is 2,700

Munafa analysis MANKIND 2200 PE might not be profitable for buyers to buy this PUT, but this could be a good opportunity for sellers to make a quick profit.

Price action analysis of 2200 PUT based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.

Price action analysis of 2200 PUT based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.

Click here to view most profitable CE and PE for Mankind Pharma Limited, both for buyers and sellers | MANKIND Most Active Call Put Options

Date Underlying price PE price PE open PE high PE low PE volume PE OI OI Change
04 Thu Dec 2206.30 62.90 62.90 62.90 62.90 -1 607,500 0%
03 Wed Dec 2205.60 64.10 66.00 66.00 64.10 -2 607,500 33.3%
02 Tue Dec 2216.40 65.70 54.45 65.70 54.45 23 455,625 28.6%
01 Mon Dec 2229.80 53.00 51.80 53.00 51.80 0 354,375 0%
28 Fri Nov 2251.00 52.80 59.00 59.55 50.00 -17 354,375 600%
27 Thu Nov 2249.30 63.95 63.95 63.95 63.95 1 50,625 -%

Charts for MANKIND 2200 PUT PE options for Mankind Pharma Limited

Select an expiry and a strike price below to view charts for those options. MANKIND All in One charts

Charts for:      

Dark shadowed line on the chart below is the current SPOT price line of underlying equity. White line on the chart is the option closing price line. Candle sticks on the chart are the OHLC for the option.

Live MANKIND 2200 PE (PUT) 27 January 2026 options price chart analysis Mankind Pharma Limited

MANKIND further analysis

Live MANKIND 2200 PE (PUT) 27 January 2026 options price chart analysis Mankind Pharma Limited

These are Live MANKIND 2200 PE (PUT) 27 January 2026 options price chart analysis Mankind Pharma Limited . Click the links below to switch between charts

 

Videos related to: Live MANKIND 2200 PE (PUT) 27 January 2026 options price chart analysis Mankind Pharma Limited

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Basics How To Trade In FnO Futures Options Stock Market

Live MANKIND 2200 PE (PUT) 27 January 2026 options price chart analysis Mankind Pharma Limited

 

Back to top